NSAV Holding Inc (NSAV)

[Trademanager]

NSAV Shanghai VSRI profit $ 165,000. U.S.D., ANNOUNCES CLOSING OF ACQUISITION OF SHANGHAI VITAL STRATEGIC MEDICAL TECHNOLOGY COMPANY
CRESCO, PA, Oct. 11, 2017 Net Savings Link, Inc. (OTC: NSAV), a medical cannabis technology and software company, announced today that the Company has completed its acquisition of world renowned Chinese medical software company, Shanghai based Vital Strategic Research Institute (VSRI). VSRI is a medical research firm with a long history of expertise in design, clinical trials and global research. VSRI has collaborated with pharmaceutical giants such as Pfizer and Bristol-Myers Squibb. For the fiscal year 2016, Shanghai posted a net profit of $ 165,000. U.S.D., compared to the fiscal year 2015,
https://globenewswire.com/news-release/2017/10/11/1144375/0/en/NSAV-ANNOUNCES-CLOSING-OF-ACQUISITION-OF-SHANGHAI-VITAL-STRATEGIC-MEDICAL-TECHNOLOGY-COMPANY.html